Overview

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Status:
Completed

Trial end date:
2008-05-01

Target enrollment:

Participant gender:

Summary

A non randomized study to validate the MATHYS Scale in a population of in and outpatients greater than or equal to 18 years of age, suffering from Bipolar Disorder I or II, and treated with olanzapine.

Phase:

Phase 3

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Olanzapine